Table 2 In-hospital outcomes of the study population after PSM
All patients (n = 5,562) | Nicotine product use (n = 2,781) | Non-use of nicotine products (n = 2,781) | p-value | |
|---|---|---|---|---|
Outcomes | ||||
In-hospital mortality | 5 (0.1) | 3 (0.1) | 2 (0.1) | 0.555 |
Unfavorable dischargea | 141 (2.6) | 78 (2.8) | 63 (2.3) | 0.158 |
Prolonged LOSa, b | 726 (13.0) | 380 (13.7) | 346 (12.4) | 0.163 |
Any complications | 485 (8.7) | 278 (10.0) | 207 (7.4) | < 0.001 |
Dysphagia | 223 (4.0) | 118 (4.2) | 105 (3.8) | 0.324 |
Dysphonia | 12 (0.2) | 6 (0.2) | 6 (0.2) | 0.975 |
AMI or CVA | 24 (0.4) | 16 (0.6) | 8 (0.3) | 0.026 |
VTE | 16 (0.3) | 9 (0.3) | 7 (0.3) | 0.623 |
Pneumonia | 22 (0.4) | 14 (0.5) | 8 (0.3) | 0.125 |
Sepsis | 18 (0.3) | 9 (0.4) | 9 (0.3) | 0.793 |
Infection | 120 (2.2) | 79 (2.9) | 41 (1.5) | < 0.001 |
SSI | 4 (0.1) | 1 (0.03) | 3 (0.1) | 0.316 |
UTI | 36 (0.7) | 20 (0.7) | 16 (0.6) | 0.432 |
Hemorrhage/hematoma | 19 (0.3) | 10 (0.4) | 9 (0.3) | 0.768 |
Respiratory failure/Mechanical ventilation | 69 (1.2) | 41 (1.5) | 28 (1.0) | 0.075 |
AKI | 22 (0.4) | 8 (0.3) | 14 (0.5) | 0.166 |
Wound complication | 9 (0.2) | 6 (0.2) | 3 (0.1) | 0.295 |
Nervous system complication | 21 (0.4) | 12 (0.4) | 9 (0.3) | 0.493 |
Digestive system complication | 5 (0.1) | 2 (0.1) | 3 (0.1) | 0.742 |